Neuropathic Pain Management Using Novel Biologics in Moderate-to-Severe Hidradenitis Suppurativa
Josephine M Feeney, Nikayla A Henderson, Tanisha M Patel, Anna K Ardoin, Ahmed I Anwar, Alaa Abd-Elsayed, Alan D Kaye · 2026
Read Neuropathic Pain Management Using Novel Biologics in Moderate-to-Severe Hidradenitis Suppurativa by Josephine M Feeney, Nikayla A Henderson, Tanisha M Patel, Anna K Ardoin, Ahmed I Anwar, Alaa Abd-Elsayed, Alan D Kaye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13529853.txt.
Description
Josephine M Feeney and co-authors review how biologic drugs might ease the nerve pain of a severe skin disease, in a 2026 paper. Hidradenitis suppurativa tunnels under the skin and hurts in two ways, from tissue damage and from nerves themselves. Three biologics are approved in the United States; the review weighs their trial pain data.
Bimekizumab showed the largest drop in skin pain and the fastest relief among the three. The authors also map how nerve pain develops in this disease and flag coming drugs. Their plea is for trials to measure nerve pain with standard tools, so relief claims can be compared fairly.
Catalog record
| CREATOR | Josephine M Feeney, Nikayla A Henderson, Tanisha M Patel, Anna K Ardoin, Ahmed I Anwar, Alaa Abd-Elsayed, Alan D Kaye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |